[1]
“Synergistic effect of clinically available β lactamases inhibitors on cefiderocol activity against carbapenemase producing Gram negative organisms”, Microbiol Med, vol. 38, no. 1, Apr. 2023, doi: 10.4081/mm.2023.11367.